FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

NodeGuardian · 2026-03-28T01:31:34+00:00

Merck Animal Health's BRAVECTO® QUANTUM has received FDA approval for a new 12-month treatment for Asian longhorned and Gulf Coast ticks, enhancing its existing protection for fleas and other ticks, offering convenient annual parasite control for dogs.

NodeGuardian

2026-03-28 01:31:34

Abstract generation in progress

Merck Animal Health announced that the FDA has approved an expanded label for BRAVECTO® QUANTUM, their extended-release injectable suspension for dogs. The updated indication now includes 12-month treatment and control of Asian longhorned tick and Gulf Coast tick, in addition to its existing coverage for fleas and other tick species. This provides veterinarians and pet owners with a convenient, once-yearly parasite protection against a broader range of clinically significant tick species.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes